Professional Documents
Culture Documents
Vulva Biopsias Histopatologia
Vulva Biopsias Histopatologia
Vulva Biopsias Histopatologia
KEYWORDS
Vulvar Biopsy Requisition Pathology Report Diagnosis
KEY POINTS
Where and how to biopsy is influenced by the lesion and location.
An ideal requisition form contains a description of the lesion, differential diagnosis/clinical
impression, and a photograph.
When reading the report, be aware of instances of poor clinical pathologic correlation or
alteration of histology caused by therapy and understand current terminology.
INTRODUCTION
Disclosure Statement: The author has no relationships with any commercial company that has a
direct financial interest in the subject matter or materials discussed in this article or with a com-
pany making a competing product.
Piedmont Pathology Associates, 1899 Tate Boulevard Southeast, Suite 1105, Hickory, NC
28601, USA
E-mail address: jasonreutter@gmail.com
PERFORMING BIOPSIES
The type of lesion and its general anatomic location should influence how the lesion is
sampled and where precisely it is sampled. We will explore different instruments and
techniques and other variables based on the lesion or type of epithelial surface.
Punch Biopsy
Punch biopsies are excellent tools for evaluating melanocytic lesions, ulcers, or any
tumors or inflammatory processes with apparent deep involvement. In the case of
melanocytic lesions, partial sampling of a melanoma is associated with misdiagnosis
and microstaging inaccuracies.1 Ideally one would completely excise a melanoma
with narrow margins, which may be achieved with a punch instrument. When not
feasible, one should attempt to get below the deepest portion of the tumor with the
punch instrument because the single most important effector on the prognosis and
treatment of melanoma is depth.2 Shave saucerization specimens have yielded a
9% transection rate of melanoma, whereas punch specimens reduced the rate to
4% versus 1.5% with excisional specimens.3
Shave Biopsy
This technique is best reserved for hair-bearing, keratinized skin. Processes
to consider for this method are superficial ones (eg, lichen sclerosus) and exophytic
tumors (eg, fibroepithelial polyps).4
Fig. 1. Illustration of suture tenting and removal with a curved iris scissors. Minimal pressure
is placed on the lesion, which is an erosive one based on mucous membranes. (Courtesy of L.
Edwards, MD, Charlotte, NC.)
High-Yield Vulvar Histopathology for the Clinician 331
Fig. 2. Hematoxylin and eosin (original magnification 100). Comparison of how the biopsy
obtained with suture tenting (A) only leaves a small divot. No tissue is crushed. Compare this
with (B) in which large divots are created with forceps and the intervening tissue is crushed
and blurred.
Kevorkian Biopsy
Gynecologists typically have this instrument readily available and may choose to use it
for vaginal biopsies. However, there is less precise manipulation of this device when
targeting an area to biopsy.4
Lichen planus
Areas of mucosal lichen planus (LP) containing Wickham striae clinically may have a
better chance of yielding more diagnostic features histologically.5 Zegarelli5 has rec-
ommended for biopsies of LP involving mucosal surfaces to attempt to capture Wick-
ham striae in the specimen in a manner that could be captured histologically in
multiple sections through the specimen (Fig. 3).
Immunobullous disorders
In general, lesional biopsies for routine histopathologic evaluation of mucosal immu-
nobullous disorders should be obtained by a broad, long technique rather than a nar-
row deep biopsy to ensure tissue intactness.6 Obtaining a perilesional specimen for
direct immunofluorescence studies (DIF) is also necessary. A distance of 10 mm or
332 Reutter
Fig. 3. Hypothetical Wickham striae in mucosal lichen planus are represented by the
squiggly line and excised along the long axis by an elliptical specimen. The red lines repre-
sent cross-sectioning of the specimen by the laboratory, which captures the striae in each
cross-section submitted for histology. (Adapted from Zegarelli DJ. Lichen planus: a simple
and reliable biopsy technique. J Oral Med 1981;36(1):19; with permission.)
greater from the lesion for the DIF sample may ensure intactness of the tissue without
sacrificing sensitivity.7 Avoiding oral steroids for a month before the biopsy may also
reduce the chance of a false-negative effect on immunoreactants.8
Fixation
The preferred media for fixation is buffered 10% formalin, with a volume of media 10
to 20 times the amount of the specimen.9 With this fixation nearly any study
including routine light microscopy, immunohistochemistry, and molecular studies
can be performed. The only exceptions are specimens for DIF, which should be
placed in Zeus or Michel media and material for cultures placed in a sterile
container.
High-Yield Vulvar Histopathology for the Clinician 333
The clinician should never underestimate the impact of carefully filling out an RF. Much
has been written about critical information for the pathologist in the RF10–14 and sug-
gestions are present in Box 1. A belief that clinical information could bias the pathol-
ogist or that the diagnosis should be obvious on histology alone should be avoided.13
Diagnoses may be made by synthesizing the clinical history, physical examination,
and laboratory and histopathologic findings. For example, it was demonstrated in a
Delphi consensus exercise among experts in vulvar disease that a diagnosis of erosive
LP may be made by any combination of at least three of six different clinical findings
and three different histopathologic findings.15
Although the RF commonly contains location and clinical impression, the
morphology of the lesion, symptoms, and previous diagnoses are often excluded.10
In general, particular points of interest include the distribution of lesions, because
LP,16 pemphigus,17 mucous membrane pemphigoid,18 and psoriasis19 often have
extravulvar involvement. Therefore, knowledge of lesions in other parts of the body
is helpful to the pathologist. Knowledge of symptoms can also be a criterion in arriving
at a diagnosis of erosive LP.15 The size of the lesion, particularly in neoplasms, both
epithelial and melanocytic, may guide the pathologist in determining their biologic sig-
nificance. Nonetheless, of paramount importance is the appearance of the lesion. This
includes such observations as erythema versus whitening versus pigmentation. If the
pathologist is distracted by pigmentation and they are unaware that this is a normal
baseline color for the patient’s skin type, they may erroneously make a diagnosis of
melanosis when that is not what the clinician is observing. Because of a distortion arti-
fact that is commonly seen in the elastic skin of the vulva, many specimens round up
and may be misinterpreted as fibroepithelial polyps. Therefore, it is important for the
clinician to let the pathologist know whether this is a flattened lesion or polypoidal
clinically.
In the case of clinical and pathologic discordance, an additional measure the pathol-
ogist may perform is deeper serial sections into the paraffin-embedded tissue block.
These additional sections have been shown to produce an alternative impression in
approximately 9% of skin samples.20
Clinical photographs are often not included in the RF,10 but are believed to be help-
ful by dermatopathologists, particularly in inflammatory lesions.21 Although this may
be readily available to pathologists who work in the same institution as the clinician,
Box 1
Recommendations for items to consider on or with a requisition form for vulvar biopsies
What the patient can tell you or what you can see
Distribution (including extravulvar)
Size of lesions
Appearance
- Erythema
- Ulcer
- Skin-colored nodule
- Pigmentation
Description of what part of lesion biopsy was taken (eg, ulcer edge, white part of lesion,
edge of blister)
Clinical impression/differential diagnosis
Photograph
334 Reutter
it is wise for the clinician to consider sending encrypted clinical photographs via email,
printing them out and attaching to the RF, sending via flash drive, or allowing to be
accessed on a secure site.21 The clinician may even consider in these photographs
to ensure that inked areas indicate where the biopsy will be performed, or postbiopsy
photographs may also let the pathologist know exactly where the sample has been
taken.
Table 1
Common histologic findings used in the evaluation of inflammatory diseases of the vulva
Modified from Lynch PJ, Moyal-Barracco M, Bogliatto F, et al. 2006 ISSVD classification of vulvar
dermatoses: pathologic subsets and their clinical correlates. J Reprod Med 2007;52(1):3–9; with
permission.
High-Yield Vulvar Histopathology for the Clinician 335
In the era of electronic health records it is not too uncommon for pathologists to
receive the clinical information in an RF populated with the correlating International
Classification of Diseases-10 code. In these instances, the clinician should consider
editing this with additional clinical data, particularly if the code does not indicate a
specific diagnosis.
The last phase, the postanalytical phase, is an equally important step for the clinician.
In this phase, clinicians need to realize potential limitations to tissue evaluation.
Table 2
Squamous intraepithelial neoplasia of the vulva as categorized by the ISSVD 2015
terminology
SUMMARY
The pathology report should be a helpful tool in the clinician’s armamentarium in eval-
uating vulvar disease. Appropriately performed biopsies coupled with informative clin-
ical data, an understanding of the limitations of vulvar tissue evaluation, and of current
terminology can only increase its effectiveness.
REFERENCES
1. Ng JC, Swain S, Dowling JP, et al. The impact of partial biopsy on histopathologic
diagnosis of cutaneous melanoma: experience of an Australian tertiary referral
service. Arch Dermatol 2010;146(3):234–9.
2. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for
cutaneous melanoma. CA Cancer J Clin 2004;54(3):131–49.
3. Mir M, Chan CS, Khan F, et al. The rate of melanoma transection with various bi-
opsy techniques and the influence of tumor transection on patient survival. J Am
Acad Dermatol 2013;68(3):452–8.
4. Edwards L. Diagnostic and therapeutic techniques. In: Edwards L, Lynch PJ, ed-
itors. Genital dermatology atlas. 2nd edition. Philadelphia: Wolters Kluwer Health
Lippincott Williams and Wilkins; 2011. p. 26–8.
5. Zegarelli DJ. Lichen planus: a simple and reliable biopsy technique. J Oral Med
1981;36(1):18–20.
6. Kumaraswamy KL, Vidhya M, Rao PK, et al. Oral biopsy: oral pathologist’s
perspective. J Cancer Res Ther 2012;8(2):192–8.
High-Yield Vulvar Histopathology for the Clinician 337
7. Sano SM, Quarracino MC, Aguas SC, et al. Sensitivity of direct immunofluores-
cence in oral diseases. Study of 125 cases. Med Oral Patol Oral Cir Bucal
2008;13(5):E287–91.
8. Jordan RC, Daniels TE, Greenspan JS, et al. Advanced diagnostic methods in
oral and maxillofacial pathology. Part II: immunohistochemical and immunofluo-
rescent methods. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;
93(1):56–74.
9. High WA, Tomasini CF, Argenziano G, et al. Basic prinicples of dermatology. In:
Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd edition. Elsevier
Saunders; 2012. p. 12–6.
10. Olson MA, Lohse CM, Comfere NI. Rates of provision of clinical information in the
skin biopsy requisition form and corresponding encounter visit note. J Pathol
Inform 2016;7:40.
11. Wong C, Peters M, Tilburt J, et al. Dermatopathologists’ opinions about the qual-
ity of clinical information in the skin biopsy requisition form and the skin biopsy
care process: a semiqualitative assessment. Am J Clin Pathol 2015;143(4):593–7.
12. Comfere NI, Peters MS, Jenkins S, et al. Dermatopathologists’ concerns and
challenges with clinical information in the skin biopsy requisition form: a mixed-
methods study. J Cutan Pathol 2015;42(5):333–45.
13. Chismar LA, Umanoff N, Murphy B, et al. The dermatopathology requisition form:
attitudes and practices of dermatologists. J Am Acad Dermatol 2015;72(2):
353–5.
14. Waller JM, Zedek DC. How informative are dermatopathology requisition forms
completed by dermatologists? a review of the clinical information provided for
100 consecutive melanocytic lesions. J Am Acad Dermatol 2010;62(2):257–61.
15. Simpson RC, Thomas KS, Leighton P, et al. Diagnostic criteria for erosive lichen
planus affecting the vulva: an international electronic-Delphi consensus exercise.
Br J Dermatol 2013;169(2):337–43.
16. Lewis FM, Shah M, Harrington CI. Vulval involvement in lichen planus: a study of
37 women. Br J Dermatol 1996;135(1):89–91.
17. Lim HW, Bystryn JC. Evaluation and management of diseases of the vulva:
bullous diseases. Clin Obstet Gynecol 1978;21(4):1007–22.
18. Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an
update. Curr Opin Ophthalmol 2005;16(5):303–7.
19. Edwards L. Pediatric genital disease. In: Edwards L, Lynch PJ, editors. Genital
dermatology atlas. 2nd edition. Philadelphia: Wolters Kluwer Health Lippincott
Williams and Wilkins; 2011. p. 254.
20. Stuart LN, Rodriguez AS, Gardner JM, et al. Utility of additional tissue sections in
dermatopathology: diagnostic, clinical and financial implications. J Cutan Pathol
2014;41(2):81–7.
21. Mohr MR, Indika SH, Hood AF. The utility of clinical photographs in dermatopa-
thologic diagnosis: a survey study. Arch Dermatol 2010;146(11):1307–8.
22. Marren P, Millard PR, Wojnarowska F. Vulval lichen sclerosus: lack of correlation
between duration of clinical symptoms and histological appearances. J Eur
Acad Venerology Dermatol 1997;8:202–16.
23. Fung MA, LeBoit PE. Light microscopic criteria for the diagnosis of early vulvar
lichen sclerosus: a comparison with lichen planus. Am J Surg Pathol 1998;22:
473–8.
24. Weyers W. Hypertrophic lichen sclerosus sine sclerosis: clues to histopathologic
diagnosis when presenting as psoriasiform lichenoid dermatitis. J Cutan Pathol
2015;42(2):118–29.
338 Reutter
25. Patterson JW. The psoriasiform reaction pattern. In: Patterson J, editor. Weedon’s
skin pathology. 4th edition. Chruchill Livingstone Elsevier; 2016. p. 89.
26. Luzar B, Calonje E. Noninfectious dermatoses of the vulva. In: Singh N,
McCluggage WG, editors. Pathology of the vulva and vagina. London: Springer;
2013. p. 61.
27. Schlosser BJ. Contact dermatitis of the vulva. Dermatol Clin 2010;28(4):697–706.
28. Lewis FM, Agarwal A, Neill SM, et al. The spectrum of histopathologic patterns
secondary to the topical application of EMLA on vulvar epithelium: clinicopath-
ological correlation in three cases. J Cutan Pathol 2013;40(8):708–13.
29. Lynch PJ, Moyal-Barracco M, Bogliatto F, et al. 2006 ISSVD classification of vulvar
dermatoses: pathologic subsets and their clinical correlates. J Reprod Med 2007;
52(1):3–9.
30. Bornstein J, Bogliatto F, Haefner HK, et al, ISSVD Terminology Committee. The
2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminol-
ogy of vulvar squamous intraepithelial lesions. J Low Genit Tract Dis 2016;20(1):
11–4.
31. Darragh TM, Colgan TJ, Cox JT, et al. The lower anogenital squamous terminol-
ogy standardization project for HPV-associated lesions: background and
consensus recommendations from the College of American Pathologists and
the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract
Dis 2012;16(3):205–42.
32. Eva LJ, Ganesan R, Chan KK, et al. Differentiated-type vulval intraepithelial
neoplasia has a high-risk association with vulval squamous cell carcinoma. Int
J Gynecol Cancer 2009;19(4):741–4.
33. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous
cell carcinoma development after diagnosis of VIN increases with age. Eur J Can-
cer 2009;45(5):851–6.